202 related articles for article (PubMed ID: 28461246)
1. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action.
Shi X; Zhu HR; Liu TT; Shen XZ; Zhu JM
Cancer Lett; 2017 Aug; 400():175-182. PubMed ID: 28461246
[TBL] [Abstract][Full Text] [Related]
2. Integrated clinical and prognostic analyses of mTOR/Hippo pathway core genes in hepatocellular carcinoma.
Feng T; Chen P; Wang T; Lai C; Yao Y
J Physiol Biochem; 2024 May; 80(2):439-449. PubMed ID: 38468074
[TBL] [Abstract][Full Text] [Related]
3. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.
Tian Y; Zhang M; Liu LX; Wang ZC; Liu B; Huang Y; Wang X; Ling YZ; Wang F; Feng X; Tu Y
Front Immunol; 2024; 15():1400744. PubMed ID: 38799446
[TBL] [Abstract][Full Text] [Related]
4. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
Li C; Xu X
Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
[TBL] [Abstract][Full Text] [Related]
5. [Research progress of non-coding RNA involved in glycolysis regulation of hepatocellular carcinoma].
Hu XF; Zhang Q; Liang ML; Zhou QN; Zhao RQ; Gong ZK; Lin WZ
Sheng Li Xue Bao; 2024 Apr; 76(2):319-328. PubMed ID: 38658380
[TBL] [Abstract][Full Text] [Related]
6. Research progress in role of Hippo signaling pathway in diagnosis and treatment for hepatocellular carcinoma.
Ma J; Huang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):637-643. PubMed ID: 34275933
[TBL] [Abstract][Full Text] [Related]
7. Role of exosomal circular RNAs as microRNA sponges and potential targeting for suppressing hepatocellular carcinoma growth and progression.
Papadopoulos N; Trifylli EM
World J Gastroenterol; 2024 Mar; 30(9):994-998. PubMed ID: 38577187
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome.
Afra F; Mahboobipour AA; Salehi Farid A; Ala M
Biomed Pharmacother; 2023 Sep; 165():115104. PubMed ID: 37393866
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications.
Shi Q; Chu Q; Zeng Y; Yuan X; Wang J; Zhang Y; Xue C; Li L
Cell Commun Signal; 2023 Dec; 21(1):359. PubMed ID: 38111040
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the role of CD24 in Hepatocellular carcinoma: Involvement of inactivated Hippo signaling and SOX4-mediated regulation.
He X; Zhang Y; Fang Q; Sun Y; Zheng X; Fu Y; Fan W; Yang L; Hong Y; Du Y; Wang Z; Chen L
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167117. PubMed ID: 38462024
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between m6A modification and non-coding RNAs in HCC.
Qiu Z; Yuan X; Wang X; Liu S
Cell Signal; 2024 May; 117():111076. PubMed ID: 38309550
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into small open reading frame-encoded micropeptides in hepatocellular carcinoma: A potential breakthrough.
Zhang Q; Liu L
Cancer Lett; 2024 Apr; 587():216691. PubMed ID: 38360139
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of non-coding RNA-encoding polypeptides in primary hepatocellular carcinoma].
Chen DM; Yu Z; Zhang ZW; Huang JL
Zhonghua Gan Zang Bing Za Zhi; 2024 Jan; 32(1):91-96. PubMed ID: 38320799
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
Wang Y; Deng B
Cancer Metastasis Rev; 2023 Sep; 42(3):629-652. PubMed ID: 36729264
[TBL] [Abstract][Full Text] [Related]
15. Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.
Lalazar G; Simon SM
Semin Liver Dis; 2018 Feb; 38(1):51-59. PubMed ID: 29471565
[TBL] [Abstract][Full Text] [Related]
16. Relationship between long non-coding RNAs and Hippo signaling pathway in gastrointestinal cancers; molecular mechanisms and clinical significance.
Fayyaz F; Eshkiki ZS; Karamzadeh AR; Moradi Z; Kaviani F; Namazi A; Karimi R; Tabaeian SP; Mansouri F; Akbari A
Heliyon; 2024 Jan; 10(1):e23826. PubMed ID: 38226210
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Non-Coding RNA Regulation of Programmed Cell Death in Hepatocellular Carcinoma.
Chen W; Ruan M; Zou M; Liu F; Liu H
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627215
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease.
Song M; Wang H; Liu C; Jin S; Liu B; Sun W
Front Pharmacol; 2024; 15():1348280. PubMed ID: 38698813
[TBL] [Abstract][Full Text] [Related]
19. Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.
Schiavoni G; Messina B; Scalera S; Memeo L; Colarossi C; Mare M; Blandino G; Ciliberto G; Bon G; Maugeri-Saccà M
J Transl Med; 2024 May; 22(1):420. PubMed ID: 38702720
[No Abstract] [Full Text] [Related]
20. Illuminating functions of evolutionarily conserved long non-coding RNAs.
He R; Zhao F
Sci China Life Sci; 2024 May; ():. PubMed ID: 38805065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
